Suranjana Mukherjee

694 total citations
20 papers, 556 citations indexed

About

Suranjana Mukherjee is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Suranjana Mukherjee has authored 20 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Cell Biology. Recurrent topics in Suranjana Mukherjee's work include Nitric Oxide and Endothelin Effects (3 papers), Cellular Mechanics and Interactions (3 papers) and Cell Adhesion Molecules Research (3 papers). Suranjana Mukherjee is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Cellular Mechanics and Interactions (3 papers) and Cell Adhesion Molecules Research (3 papers). Suranjana Mukherjee collaborates with scholars based in India, Canada and United States. Suranjana Mukherjee's co-authors include Subrata Chakrabarti, Shali Chen, Chandan Chakraborty, Mark Cukiernik, Sandra Rainbow, P. S. Sharp, Dónal B. Downey, Koel Chaudhury, Pradyumna Kumar Mishra and Sanjukta Dasgupta and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Journal of Investigative Dermatology.

In The Last Decade

Suranjana Mukherjee

17 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suranjana Mukherjee India 13 232 95 84 75 75 20 556
Alexander J. Glassford United States 8 262 1.1× 73 0.8× 213 2.5× 204 2.7× 25 0.3× 9 989
Shun‐Yao Ko Taiwan 13 221 1.0× 154 1.6× 152 1.8× 27 0.4× 29 0.4× 21 607
Hyun Joung Lim South Korea 12 242 1.0× 16 0.2× 141 1.7× 154 2.1× 33 0.4× 20 776
Yanlin Yang China 16 354 1.5× 37 0.4× 35 0.4× 32 0.4× 42 0.6× 38 736
Wanchao Ma United States 9 253 1.1× 285 3.0× 116 1.4× 15 0.2× 20 0.3× 13 678
Liang Xie United States 13 248 1.1× 19 0.2× 108 1.3× 116 1.5× 37 0.5× 20 568
A.S. Reddi United States 12 114 0.5× 96 1.0× 97 1.2× 126 1.7× 62 0.8× 43 524
Gang Xi United States 19 671 2.9× 33 0.3× 176 2.1× 92 1.2× 90 1.2× 50 1.0k
Takuya Kitamura Japan 12 191 0.8× 40 0.4× 61 0.7× 41 0.5× 12 0.2× 25 608
Y. S. Kim South Korea 6 160 0.7× 84 0.9× 95 1.1× 25 0.3× 18 0.2× 10 584

Countries citing papers authored by Suranjana Mukherjee

Since Specialization
Citations

This map shows the geographic impact of Suranjana Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suranjana Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suranjana Mukherjee more than expected).

Fields of papers citing papers by Suranjana Mukherjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suranjana Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suranjana Mukherjee. The network helps show where Suranjana Mukherjee may publish in the future.

Co-authorship network of co-authors of Suranjana Mukherjee

This figure shows the co-authorship network connecting the top 25 collaborators of Suranjana Mukherjee. A scholar is included among the top collaborators of Suranjana Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suranjana Mukherjee. Suranjana Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chini, Claudia C.S., Erika M. Palmieri, Sonu Kashyap, et al.. (2025). Chronic Cellular NAD Depletion Activates a Viral Infection‐Like Interferon Response Through Mitochondrial DNA Leakage. Aging Cell. 24(9). e70135–e70135.
2.
3.
Mukherjee, Suranjana, et al.. (2023). Impact of individualised homoeopathy in plaque psoriasis – A case report. 6. 67–72. 1 indexed citations
4.
Mishra, Pradyumna Kumar, Arpit Bhargava, Roshani Kumari, et al.. (2022). Integrated mitoepigenetic signalling mechanisms associated with airborne particulate matter exposure: A cross-sectional pilot study. Atmospheric Pollution Research. 13(5). 101399–101399. 18 indexed citations
5.
Singh, Apoorva, Pooja Ghosh, Suranjana Mukherjee, et al.. (2022). Transition metallo-curcumin complexes: a new hope for endometriosis?. Journal of Materials Chemistry B. 10(46). 9682–9698. 5 indexed citations
6.
Mukherjee, Suranjana, Sanjukta Dasgupta, Pradyumna Kumar Mishra, & Koel Chaudhury. (2021). Air pollution-induced epigenetic changes: disease development and a possible link with hypersensitivity pneumonitis. Environmental Science and Pollution Research. 28(40). 55981–56002. 51 indexed citations
7.
Mukherjee, Suranjana, Biswajoy Ghosh, Basudev Lahiri, et al.. (2021). Comprehensive Evaluation of PAXgene Fixation on Oral Cancer Tissues Using Routine Histology, Immunohistochemistry, and FTIR Microspectroscopy. Biomolecules. 11(6). 889–889. 3 indexed citations
8.
Das, Ankita, Suranjana Mukherjee, Amrita Chaudhary, et al.. (2021). Improved Mesenchymal Stem Cell Proliferation, Differentiation, Epithelial Transition, and Restrained Senescence on Hierarchically Patterned Porous Honey Silk Fibroin Scaffolds. ACS Applied Bio Materials. 4(5). 4328–4344. 20 indexed citations
9.
Mukherjee, Suranjana, et al.. (2015). Role of Cortactin Homolog HS1 in Transendothelial Migration of Natural Killer Cells. PLoS ONE. 10(2). e0118153–e0118153. 16 indexed citations
10.
Charafeddine, Rabab A., David Schairer, Brian O’Rourke, et al.. (2015). Fidgetin-Like 2: A Microtubule-Based Regulator of Wound Healing. Journal of Investigative Dermatology. 135(9). 2309–2318. 51 indexed citations
11.
Onken, Michael D., et al.. (2014). Endothelial monolayers and transendothelial migration depend on mechanical properties of the substrate. Cytoskeleton. 71(12). 695–706. 36 indexed citations
12.
Mukherjee, Suranjana, Shannon F. Stewman, Jeremy Metz, et al.. (2012). Human Fidgetin is a microtubule severing the enzyme and minus-end depolymerase that regulates mitosis. Cell Cycle. 11(12). 2359–2366. 50 indexed citations
13.
Basu, S., Suranjana Mukherjee, & Samit Adhya. (2008). Proton-guided movements of tRNA within the Leishmania mitochondrial RNA import complex. Nucleic Acids Research. 36(5). 1599–1609. 2 indexed citations
14.
Cukiernik, Mark, Denise Hileeto, Terry Evans, et al.. (2004). Vascular endothelial growth factor in diabetes induced early retinal abnormalities. Diabetes Research and Clinical Practice. 65(3). 197–208. 30 indexed citations
15.
Sharp, P. S., Sandra Rainbow, & Suranjana Mukherjee. (2003). Serum levels of low molecular weight advanced glycation end products in diabetic subjects. Diabetic Medicine. 20(7). 575–579. 60 indexed citations
16.
Cukiernik, Mark, et al.. (2003). Heme oxygenase in the retina in diabetes. Current Eye Research. 27(5). 301–308. 34 indexed citations
17.
Chen, Shali, Suranjana Mukherjee, Chandan Chakraborty, & Subrata Chakrabarti. (2003). High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-κB and AP-1. American Journal of Physiology-Cell Physiology. 284(2). C263–C272. 115 indexed citations
18.
Hileeto, Denise, Mark Cukiernik, Suranjana Mukherjee, et al.. (2002). Contributions of endothelin‐1 and sodium hydrogen exchanger‐1 in the diabetic myocardium. Diabetes/Metabolism Research and Reviews. 18(5). 386–394. 43 indexed citations
19.
Chakrabarti, Subrata, et al.. (2002). Alteration of Endothelins: A Common Pathogenetic Mechanism in Chronic Diabetic Complications. Journal of Diabetes Research. 3(4). 217–231. 12 indexed citations
20.
Chakrabarti, Subrata, Mark Cukiernik, Suranjana Mukherjee, & Shali Chen. (2000). Therapeutic potential of endothelin receptor antagonists in diabetes. Expert Opinion on Investigational Drugs. 9(12). 2873–2888. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander J. Glassford Breakdown of academic impact, for papers by Shun‐Yao Ko Breakdown of academic impact, for papers by Hyun Joung Lim Breakdown of academic impact, for papers by Yanlin Yang Breakdown of academic impact, for papers by Wanchao Ma Breakdown of academic impact, for papers by Liang Xie Breakdown of academic impact, for papers by A.S. Reddi Breakdown of academic impact, for papers by Gang Xi Breakdown of academic impact, for papers by Takuya Kitamura Breakdown of academic impact, for papers by Y. S. Kim
Rankless by CCL
2026